USD 0.24
(-0.49%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 1.15 Million USD | 0.0% |
2023 | - USD | 0.0% |
2022 | - USD | -100.0% |
2021 | 873 Thousand USD | -37.2% |
2020 | 1.39 Million USD | -82.0% |
2019 | 7.72 Million USD | 0.0% |
2018 | - USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 59 Thousand USD | 0.0% |
2024 Q4 | 470 Thousand USD | 20.2% |
2024 Q2 | 239 Thousand USD | 305.08% |
2024 Q3 | 391 Thousand USD | 63.6% |
2024 FY | 1.15 Million USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 FY | - USD | -100.0% |
2022 Q1 | - USD | -100.0% |
2022 Q3 | - USD | 0.0% |
2021 Q4 | 145.62 Thousand USD | -2.26% |
2021 Q2 | 350 Thousand USD | 52.73% |
2021 Q3 | 149 Thousand USD | -57.43% |
2021 FY | 873 Thousand USD | -37.2% |
2021 Q1 | 229.16 Thousand USD | 216.12% |
2020 Q4 | -197.34 Thousand USD | -162.77% |
2020 FY | 1.39 Million USD | -82.0% |
2020 Q3 | 314.37 Thousand USD | -51.3% |
2020 Q2 | 645.6 Thousand USD | 2.89% |
2020 Q1 | 627.46 Thousand USD | -91.88% |
2019 Q1 | - USD | 0.0% |
2019 FY | 7.72 Million USD | 0.0% |
2019 Q4 | 7.72 Million USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 12.05 Million USD | 90.389% |
BrainsWay Ltd. | 31.78 Million USD | 96.354% |
Cerus Corporation | 156.36 Million USD | 99.259% |
Envoy Medical, Inc. | 316 Thousand USD | -266.772% |
electroCore, Inc. | 16.03 Million USD | 92.77% |
Helius Medical Technologies, Inc. | 644 Thousand USD | -79.969% |
IceCure Medical Ltd | 3.22 Million USD | 64.107% |
Inogen, Inc. | 315.66 Million USD | 99.633% |
OrthoPediatrics Corp. | 148.73 Million USD | 99.221% |
Lucid Diagnostics Inc. | 2.42 Million USD | 52.265% |
Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -217.535% |
MaxCyte, Inc. | 41.28 Million USD | 97.193% |
NeuroOne Medical Technologies Corporation | 1.95 Million USD | 40.638% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -946.52% |
Orthofix Medical Inc. | 746.64 Million USD | 99.845% |
PAVmed Inc | 2.45 Million USD | 52.732% |
Rapid Micro Biosystems, Inc. | 22.51 Million USD | 94.853% |
RxSight, Inc. | 89.07 Million USD | 98.699% |
Sight Sciences, Inc. | 81.05 Million USD | 98.57% |
SI-BONE, Inc. | 138.88 Million USD | 99.166% |
TELA Bio, Inc. | 58.45 Million USD | 98.017% |
Treace Medical Concepts, Inc. | 187.11 Million USD | 99.381% |
Vivos Therapeutics, Inc. | 13.8 Million USD | 91.602% |
Acutus Medical, Inc. | 7.16 Million USD | 83.822% |
Talis Biomedical Corporation | 412 Thousand USD | -181.311% |
Spectral AI, Inc. | 18.05 Million USD | 93.581% |
Nano-X Imaging Ltd. | 9.9 Million USD | 88.299% |
CVRx, Inc. | 39.29 Million USD | 97.051% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 968.7 Thousand USD | -19.644% |
Bioventus Inc. | 512.34 Million USD | 99.774% |
Venus Concept Inc. | 76.35 Million USD | 98.482% |
TriSalus Life Sciences, Inc. | 18.51 Million USD | 93.739% |
LivaNova PLC | 1.15 Billion USD | 99.9% |
908 Devices Inc. | 50.22 Million USD | 97.693% |
Alphatec Holdings, Inc. | 482.26 Million USD | 99.76% |
Nemaura Medical Inc. | 77.04 Thousand USD | -1404.335% |
NeuroPace, Inc. | 65.42 Million USD | 98.228% |
LENSAR, Inc. | 42.16 Million USD | 97.251% |
Apyx Medical Corporation | 52.34 Million USD | 97.786% |
Cutera, Inc. | 212.36 Million USD | 99.454% |
STRATA Skin Sciences, Inc. | 33.35 Million USD | 96.526% |
BioSig Technologies, Inc. | 18 Thousand USD | -6338.889% |
Anika Therapeutics, Inc. | 166.66 Million USD | 99.305% |
ClearPoint Neuro, Inc. | 23.95 Million USD | 95.162% |
Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.925% |
Axonics, Inc. | 366.37 Million USD | 99.684% |
Outset Medical, Inc. | 130.37 Million USD | 99.111% |
IRIDEX Corporation | 51.86 Million USD | 97.766% |
PROCEPT BioRobotics Corporation | 136.19 Million USD | 99.149% |
IRadimed Corporation | 65.56 Million USD | 98.232% |
Tivic Health Systems, Inc. | 1.17 Million USD | 1.446% |
INVO Bioscience, Inc. | 3.02 Million USD | 61.63% |
Telesis Bio, Inc. | 27.5 Million USD | 95.787% |
Viemed Healthcare, Inc. | 183 Million USD | 99.367% |
Varex Imaging Corporation | 811 Million USD | 99.857% |
Quipt Home Medical Corp. | 221.74 Million USD | 99.477% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Pulmonx Corporation | 68.67 Million USD | 98.312% |
Dynatronics Corporation | 32.53 Million USD | 96.438% |
Modular Medical, Inc. | - USD | -Infinity% |
ReShape Lifesciences Inc. | 8.67 Million USD | 86.644% |
Semler Scientific, Inc. | 68.18 Million USD | 98.3% |
InMode Ltd. | 492.04 Million USD | 99.764% |
Bruker Corporation | 2.96 Billion USD | 99.961% |
Cytosorbents Corporation | 36.34 Million USD | 96.811% |
DexCom, Inc. | 3.62 Billion USD | 99.968% |
Align Technology, Inc. | 3.86 Billion USD | 99.97% |
Viveve Medical, Inc. | 6.42 Million USD | 81.964% |
ZimVie Inc. | 457.43 Million USD | 99.747% |
Movano Inc. | - USD | -Infinity% |
Cytek Biosciences, Inc. | 193.01 Million USD | 99.4% |
Nexalin Technology, Inc. | 110.74 Thousand USD | -946.52% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 747.71 Million USD | 99.845% |
Profound Medical Corp. | 7.33 Million USD | 84.19% |
Insulet Corporation | 1.69 Billion USD | 99.932% |
enVVeno Medical Corporation | - USD | -Infinity% |
Surmodics, Inc. | 126.07 Million USD | 99.081% |
iCAD, Inc. | 17.31 Million USD | 93.308% |
Nuwellis, Inc. | 8.86 Million USD | 86.925% |
Biotricity, Inc. | 12.06 Million USD | 90.392% |
iRhythm Technologies, Inc. | 492.68 Million USD | 99.765% |
Aethlon Medical, Inc. | - USD | -Infinity% |
InspireMD, Inc. | 6.2 Million USD | 81.322% |
PAVmed Inc. | 2.45 Million USD | 52.732% |
BIOLASE, Inc. | 49.16 Million USD | 97.643% |
FONAR Corporation | 102.88 Million USD | 98.873% |
AxoGen, Inc. | 159.01 Million USD | 99.271% |
Vivani Medical, Inc. | - USD | -Infinity% |
Tactile Systems Technology, Inc. | 274.42 Million USD | 99.578% |
Inari Medical, Inc. | 493.63 Million USD | 99.765% |
UFP Technologies, Inc. | 400.07 Million USD | 99.71% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 18.6 Thousand USD | -6131.183% |
Tenon Medical, Inc. | 2.92 Million USD | 60.417% |
Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
Co-Diagnostics, Inc. | 6.81 Million USD | 82.986% |
AdaptHealth Corp. | 3.2 Billion USD | 99.964% |
Sintx Technologies, Inc. | 2.62 Million USD | 55.881% |
NanoVibronix, Inc. | 2.28 Million USD | 49.233% |
Quanterix Corporation | 122.36 Million USD | 99.053% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Sensus Healthcare, Inc. | 24.4 Million USD | 95.251% |
Pacific Biosciences of California, Inc. | 200.52 Million USD | 99.422% |
TransMedics Group, Inc. | 241.62 Million USD | 99.52% |
ReWalk Robotics Ltd. | 13.85 Million USD | 91.634% |
NeuroMetrix, Inc. | 5.9 Million USD | 80.361% |
Hyperfine, Inc. | 11.03 Million USD | 89.494% |
Establishment Labs Holdings Inc. | 165.15 Million USD | 99.298% |
Biomerica, Inc. | 5.41 Million USD | 78.596% |
Bone Biologics Corporation | - USD | -Infinity% |
AVITA Medical, Inc. | 50.56 Million USD | 97.708% |
Bluejay Diagnostics, Inc. | - USD | -Infinity% |
Silk Road Medical, Inc | 177.13 Million USD | 99.346% |